000			01576nam a2200229Ia 4500
003			MX-MdCICY
005			20250625162452.0
040			_cCICY
090			_aB-20599
245	1	0	_aLearning from COVID-19: How drug hunters can prepare for the next pandemic
490	0		_vDrug Discovery Today, 28(10), 103723, 2023
520	3		_aOver 3 years, the SARS-CoV-2 pandemic killed nearly 7 million people and infected more than 767 million globally. During this time, our very small company was able to contribute to antiviral drug discovery efforts through global collaborations with other researchers, which enabled the identification and repurposing of multiple molecules with activity against SARS-CoV-2 including pyronaridine tetraphosphate, tilorone, quinacrine, vandetanib, lumefantrine, cetylpyridinium chloride, raloxifene, carvedilol, olmutinib, dacomitinib, crizotinib, and bosutinib. We highlight some of the key findings from this experience of using different computational and experimental strategies, and detail some of the challenges and strategies for how we might better prepare for the next pandemic so that potential antiviral treatments are available for future outbreaks.
650	1	4	_aANTIVIRALS
650	1	4	_aCOVID-19
650	1	4	_aEBOLA
700	1	2	_aPuhl, A. C.
700	1	2	_aLane, T.
700	1	2	_aEkins, S.
856	4	0	_uhttps://drive.google.com/file/d/1qbpUtD-7bZIHJevhlpQGT0KYQmIA-jiz/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx
942			_2Loc _cREF1
008			250602s9999 xx |||||s2 |||| ||und|d
999			_c54685 _d54685